These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 2779976)

  • 41. Characterization of ocular hypertension induced by adenosine agonists.
    Crosson CE; Gray T
    Invest Ophthalmol Vis Sci; 1996 Aug; 37(9):1833-9. PubMed ID: 8759351
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [The effect of local corticosteroid therapy on ophthalmic tonus and ocular hydro- and hemodynamics in experimental inflammatory pathology].
    Chaĭka LA; Povolotskaia VA
    Eksp Klin Farmakol; 1995; 58(3):62-4. PubMed ID: 7663304
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Reversal of the anti-inflammatory effects of dexamethasone by the glucocorticoid antagonist RU 38486.
    Peers SH; Moon D; Flower RJ
    Biochem Pharmacol; 1988 Feb; 37(3):556-7. PubMed ID: 3337749
    [No Abstract]   [Full Text] [Related]  

  • 44. Topical SDZ GLC-756, a novel dopamine D-1 antagonist and D-2 agonist, lowers intraocular pressure in conscious rabbits.
    Prünte C; Nuttli I; Markstein R
    Jpn J Ophthalmol; 1996; 40(2):167-73. PubMed ID: 8876383
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Effect of long-term subconjunctival administration of Diamox (acetazolamide) on the ocular tension in rabbit.
    Kimura R
    Albrecht Von Graefes Arch Klin Exp Ophthalmol; 1978 Mar; 205(4):221-7. PubMed ID: 306766
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Topical corticosteroid response in clinically normal eyes of Negroes forty years and older.
    Deutsch A; Hiatt RL; Risser CF
    Ann Ophthalmol; 1971 Jun; 3(6):604-6. PubMed ID: 5164433
    [No Abstract]   [Full Text] [Related]  

  • 47. Does laser trabeculoplasty prevent steroid glaucoma?
    Galin MA; Hirschman H; Gould H; Hofmann I
    Ophthalmic Surg Lasers; 2000; 31(2):107-10. PubMed ID: 10743920
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Comparative ocular pressure elevation by medrysone, fluorometholone, and dexamethasone phosphate.
    Mindel JS; Tavitian HO; Smith H; Walker EC
    Arch Ophthalmol; 1980 Sep; 98(9):1577-8. PubMed ID: 6893544
    [TBL] [Abstract][Full Text] [Related]  

  • 49. RU 486 inhibits peripheral effects of glucocorticoids in humans.
    Gaillard RC; Poffet D; Riondel AM; Saurat JH
    J Clin Endocrinol Metab; 1985 Dec; 61(6):1009-11. PubMed ID: 4055982
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Intraocular pressure response to topical epinephrine and HLA-B12.
    Shin DH; Kass MA; Becker B
    Arch Ophthalmol; 1978 Jun; 96(6):1012-3. PubMed ID: 655937
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Increased adrenocorticotropin, cortisol, and arginine vasopressin secretion in primates after the antiglucocorticoid steroid RU 486: dose response relationships.
    Healy DL; Chrousos GP; Schulte HM; Gold PW; Hodgen GD
    J Clin Endocrinol Metab; 1985 Jan; 60(1):1-4. PubMed ID: 2981083
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Effects of topical natural ergot alkaloids on intraocular pressure and aqueous humor dynamics in ocular normotensive rabbits.
    Puras G; Santafé J; Segarra J; Garrido M; Melena J
    J Ocul Pharmacol Ther; 2002 Feb; 18(1):41-52. PubMed ID: 11858614
    [TBL] [Abstract][Full Text] [Related]  

  • 53. The reproducibility of the intraocular pressure response to dexamethasone.
    Palmberg PF; Mandell A; Wilensky JT; Podos SM; Becker B
    Am J Ophthalmol; 1975 Nov; 80(5):844-56. PubMed ID: 1190278
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Dexamethasone ocular hypertension in the clinically normal eye. II. The untreated eye, outflow facility, and concentration.
    Armaly MF
    Arch Ophthalmol; 1966 Jun; 75(6):776-82. PubMed ID: 5936805
    [No Abstract]   [Full Text] [Related]  

  • 55. Ocular hypotensive activity of pirbuterol eye drops in rabbits.
    Bonomi L; Perfetti S; Bellucci R; De Franco I
    J Ocul Pharmacol; 1991; 7(3):191-4. PubMed ID: 1686050
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Topical rivastigmine, a selective acetylcholinesterase inhibitor, lowers intraocular pressure in rabbits.
    Goldblum D; Garweg JG; Böhnke M
    J Ocul Pharmacol Ther; 2000 Feb; 16(1):29-35. PubMed ID: 10673128
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Effect of Eye Drops Containing Disulfiram and Low-Substituted Methylcellulose in Reducing Intraocular Pressure in Rabbit Models.
    Nagai N; Yoshioka C; Mano Y; Ito Y; Okamoto N; Shimomura Y
    Curr Eye Res; 2015; 40(10):990-1000. PubMed ID: 25330366
    [TBL] [Abstract][Full Text] [Related]  

  • 58. The ocular hypertensive effects of topical 0.1% dexamethasone in beagles with inherited glaucoma.
    Gelatt KN; Mackay EO
    J Ocul Pharmacol Ther; 1998 Feb; 14(1):57-66. PubMed ID: 9493783
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Oculohypotensive effect of perindopril in acute and chronic models of glaucoma in rabbits.
    Mehta A; Iyer L; Parmar S; Shah G; Goyal R
    Can J Physiol Pharmacol; 2010 May; 88(5):595-600. PubMed ID: 20555429
    [TBL] [Abstract][Full Text] [Related]  

  • 60. The new steroid analog RU 486 inhibits glucocorticoid action in man.
    Bertagna X; Bertagna C; Luton JP; Husson JM; Girard F
    J Clin Endocrinol Metab; 1984 Jul; 59(1):25-8. PubMed ID: 6327758
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.